Transplants
Spike Seen in Transplants for Fatty Liver Disease
Spike Seen in Transplants for Fatty Liver Disease By Charles Bankhead, Staff Writer, MedPage Today Published: December 20, 2011 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner The frequency of liver transplantation for nonalcoholic steatohepatitis (NASH) increased six-fold over…
Read MoreSeniors Are Good Candidates for Liver Transplants
Seniors Are Good Candidates for Liver Transplants Although the risks associated with most operations are much higher for people over the age of 65, studies prove that liver transplant surgery is an exception. As transplant centers learn of this realization, age will no longer limit a person’s transplant eligibility. by Nicole Cutler, L.Ac. The liver…
Read MoreMedical marijuana jeopardizes liver transplant
Medical marijuana jeopardizes liver transplant A cancer patient is removed from the transplant list at Cedars-Sinai for using medical marijuana and for failing to show up for a drug test. He is hoping the hospital will reconsider. Norman Smith, who has been fighting cancer for two years, needs a new liver. He was placed on…
Read MoreManagement of Recurrent Hepatitis C Following Liver Transplantation: Fibrosing Cholestatic Hepatitis
Management of Recurrent Hepatitis C Although it occurs in less than 10% of transplant recipients with chronic HCV, a severe and rapidly progressive form of recurrent HCV infection characterized by cholestatic disease has a major impact on survival. In contrast to a chronic hepatitis observed in most patients with recurrent HCV, this syndrome is defined…
Read MoreLiver Transplantations for NASH-Cirrhosis Grew More than 600% over Past Decade
Liver Transplantations for NASH Nonalcoholic steatohepatitis (NASH) occurs when fat builds up in the liver. This accumulation of fat damages the liver and leads to cirrhosis. NASH is rapidly increasing in the U.S. mainly related to the epidemics of obesity and diabetes. As a result, the proportion of liver transplantations performed for NASH cirrhosis rose…
Read MoreLiver Transplantation, Evaluation and Transplantation
Evaluation and Transplantation Liver transplantation is an effective and accepted therapy for a variety of chronic, irreversible liver diseases for which no other therapy has proved to be satisfactory. The liver can be transplanted as an extra (auxiliary) organ at another site or in the orthotopic location after the removal of the host liver. The…
Read MoreHepatitis C and Liver Transplants
Hepatitis C and Liver Transplants Most people know him as the bad guy JR Ewing on the TV show “Dallas.” But lately the actor who played the part, Larry Hagman, has adopted a different role: champion for the cause of organ transplants. In 1995, Hagman, who had advanced cirrhosis, received a life-saving liver transplant. Since…
Read MoreAdult-to-Adult Living Donor Liver Transplantation
Adult-to-Adult Living Donor Liver Transplantation Emmet B. Keeffe, M.D. Stanford University Medical Center Stanford, California Liver transplantation is the accepted treatment for most acute and chronic liver diseases resulting in liver failure; however, the scarcity of cadaveric donors has become an insurmountable problem limiting the application of liver transplantation (1). To increase the donor supply,…
Read More